Delivery Order SPE2DB20D2104-SPE2DB25FMWGF
- Not listed
- The Defense Logistics Agency awarded a $7,006.54 delivery order to AmerisourceBergen Drug Corp for ORENCIA CLICKJECT 125 MG/ML, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, awarded on July 21, 2025, represents a non-set-aside competitive award with an ultimate completion date of July 22, 2025. The contract will be performed at the contractor's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $10,782.12 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in rheumatoid arthritis treatment. This competitively awarded, firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a $26,329.73 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitive award carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) has awarded a $52,979.25 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of ORENCIA CLICKJECT 125 MG/MLML pharmaceutical products. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract...
- The Defense Logistics Agency (DLA) awarded a $17,548.12 delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other inflammatory conditions. The contract, awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $14,837.03 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL on July 23, 2025, with an ultimate completion date of July 24, 2025. This non-set-aside award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled at AmerisourceBergen's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,022.20 firm-fixed-price delivery order is for the supply of ORENCIA CLICKJECT 125 MG/MLML, a specialty medication. The contract has an ultimate completion date of February 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The Defense Logistics Agency awarded a delivery order valued at $7,188.08 to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL, a specialty pharmaceutical product. The award was made on July 24, 2025, with an ultimate completion date of July 25, 2025, under firm fixed pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a competitive award to a major pharmaceutical...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,471.20 firm-fixed-price delivery order is for the supply of ORENCIA CLICKJECT 125 MG/MLML, a specialty medication, with an ultimate completion date of October 31, 2024. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,226.98 firm fixed-price delivery order is for the supply of ORENCIA CLICKJECT 125 MG/MLML, a specialty medication. The contract has an ultimate completion date of November 7, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMWGFDelivery Order
The Defense Logistics Agency awarded a $31,264.81 delivery order to AmerisourceBergen Drug Corp for ORENCIA CLICKJECT 125 MG/ML on July 23, 2025, with ultimate completion scheduled for July 24, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award reflects AmerisourceBergen's established role as a critical pharmaceutical distributor within the federal medical supply chain, specifically supporting military and veteran healthcare systems. ORENCIA CLICKJECT is a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions, representing the type of specialized pharmaceutical commodity within the company's extensive portfolio of brand-name medications, generics, vaccines, and medical devices supplied through DLA contracts. The broader SPE2DX vehicle provides flexible procurement capabilities for federal healthcare customers including the Defense Health Agency and U.S. Coast Guard, with AmerisourceBergen competing against multiple other regional contractors under the DLA's Pharmaceutical Prime Vendor Global Program structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.3k | 7/23/25 |